Securepharma Expansion (IIC-11608-01)

  • Dominican Republic
Where the impacts of the investment may be experienced.
Specific Location
Santiago de los Caballeros
Whenever identified, the area within countries where the impacts of the investment may be experienced. Exact locations of projects may not be identified fully or at all in project documents. Please review updated project documents and community-led assessments.
Financial Institutions
  • IDB Invest
International, regional and national development finance institutions. Many of these banks have a public interest mission, such as poverty reduction.
Bank Risk Rating
Risk rating varies among banks and may refer only to the particular investment and not to the risk for the project as a whole. Projects marked 'U' have an 'Unknown' risk rating at the time of disclosure.
Voting Date
Nov 8, 2016
The estimate day the bank will vote on a proposed investment. The decision dates may change, so review updated project documents or contact the EWS team.
The Securepharma Partnership S.R.L.
The holder of the loan, grant, or other investment.
  • Industry and Trade
The service or industry focus of the investment. A project can have several sectors.
Investment Type(s)
The categories of the bank investment: loan, grant, etc.
Investment Amount (USD)
$ 4.00 million
Value listed on project documents at time of disclosure. If necessary, converted to USD$. Please review updated project documents for more information.
Project Cost (USD)
$ 5.10 million
Value listed on project documents at time of disclosure. If necessary, converted to USD$. Please see updated project documentation for more information.
Primary Source

Original disclosure @ IIC website

Updated in EWS Aug 23, 2018

Disclosed by Bank Oct 5, 2016

Contribute Information
Can you contribute information about this project?
Contact the EWS Team

Project Description

From the Inter-American Development Bank Invest (IDB Invest), formerly the Inter-American Investment Corporation (IIC):

The project consists of the installation and operation of: a) a production line for baby wipes, first of its kind in the country; and b) a production line for chicken broth. Both will be located in the city of Santiago de los Caballeros, Dominican Republic. Securepharma, the Borrower, is an importer, wholesale distributor, and (to a lesser extent) packager of personal hygiene products, baby products, and foodstuffs.

The objective of the loan is to assist in efforts to expand Securepharma's manufacturing capacity while following international standards. The project will also contribute to increasing capacity to produce basic consumer goods and make them available to the population.



Early Warning System Project Analysis

According to the IIC Environmental and Social Sustainability Policy, this is a Category B project, as potential environmental and social risks and impacts are generally limited to the project site, are largely reversible, and can be mitigated via measures that are readily available and feasible to implement in the context of the operation.

Investment Description
  • IDB Invest

The total cost of the project is estimated at US$5.1 million, including working capital requirements. The IIC would grant a loan of US$4.0 million.

Private Actors
Contact Information


The Independent Consultation and Investigation Mechanism (MICI) is the independent complaint mechanism and fact-finding body for people who have been or are likely to be adversely affected by an Inter-American Development Bank (IDB) or Inter-American Investment Corporation (IIC)-funded project. If you submit a complaint to MICI, they may assist you in addressing the problems you raised through a dispute-resolution process with those implementing the project and/or through an investigation to assess whether the IDB or IIC is following its own policies for preventing or mitigating harm to people or the environment. You can submit a complaint by sending an email to You can learn more about the MICI and how to file a complaint at,1752.html (in English) or,1752.html (Spanish).